New Hope in Depression Research - PsyRx Reports Promising Findings from an Ibogaine Study
The study, conducted in 105 mice, examined the effects of ibogaine, citalopram and their combination on behavioral measures associated with depression and anxiety TEL AVIV, Israel, Oct. 21, 2026 /PRNewswire/ -- PsyRx (TASE: PSRX) reports that it has received results from a preclinical...
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


